Walder Wyss advised Bank J. Safra Sarasin AG on the deal. Bank J. Safra Sarasin AG acquired the 100% of the shares of MIV Asset Management...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Swiss Life Holding AG on the deal. Swiss Life Holding AG has announced to repurchase own registered shares up to a maximum repurchase...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised CorFlow Therapeutics AG on the deal. Kellerhals Carrard advised Broadview Ventures and Panakes Partners. CorFlow Therapeutics AG completed a series B financing round...
You must be a Standard 1 Year member to access this content.
Bär & Karrer acted as legal advisor to RES in this transaction, Walder Wyss advised Sulzer & Schmid Laboratories AG. RES, a leading independent renewable energy...
You must be a Standard 1 Year member to access this content.
Walder Wyss acted as Swiss legal advisor to Acronis. EQT was advised by Milbank and Bär & Karrer. Acronis and EQT announced that EQT X fund...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Bregal Unternehmerkapital; Bär & Karrer acted for Capvis; Niederer Kraft Frey acted for BSI Software AG. Bregal Unternehmerkapital acquired a majority stake in...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised AnaPico’s shareholders on the transaction. Keysight Technologies, Inc., with its registered seat in Santa Rosa, California, USA (NYSE: KEYS), acquired all shares in...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised SkyCell AG on all legal and tax aspects of this transaction. SkyCell AG closed its $116 million Series D financing round which embarked...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised KLAR Partners on the transaction. KLAR Partners Limited acquired all shares in BÜHLMANN Laboratories AG. BÜHLMANN Laboratories is a Swiss company, located in...
You must be a Standard 1 Year member to access this content.
Walder Wyss has advised Houzy on the transaction. Houzy AG and its two anchor shareholders, Baloise Versicherung AG and UBS Switzerland AG, announced that Houzy and...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Boehringer Ingelheim in the transaction. Boehringer Ingelheim announced the acquisition of privately-held T3 Pharmaceuticals AG, a clinical stage Swiss biotech company, for an...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised SkyCell AG on all legal and tax aspects on this transaction. Swiss based SkyCell AG has completed a USD 57 million equity financing...
You must be a Standard 1 Year member to access this content.
